Macular degeneration trials in Russia

1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Compare GNR-139 and Eylea® in Patients With nAMD

  Where

  Cheboksary, Chelyabinsk, Ivanovo, Kazan', Moscow, Nizhny Novgorod, Novosibirsk, Omsk, Saint Petersburg, Vladimir, Yekaterinburg

  Age

  50 years and over

  People

  180

  Run by

  AO GENERIUM

  See details and how to joinNCT07844148